Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes?

The Medical Journal of Australia ISSN: 0025729X 1 June 2009 190 11 614-615 ©The Medical Journal of Australia 2009 www.mja.com.au Editorials diabetes mellitus. Diabetes Australia, the Royal Aust of General Practitioners, and the National Health Research Council (NHMRC), as well as numerous a the United States and United Kingdom, have all r low-dose aspirin for men and women with diabetes ( Until very recently, there were no randomised cont aspirin use for people with diabetes to provide the evid Robust evidence remains to be gathered

[1]  V. Fuster,et al.  Diabetes and aspirin: beware of underpowered negative trials , 2009, Nature Clinical Practice Cardiovascular Medicine.

[2]  A. Nicolucci.  Aspirin for primary prevention of cardiovascular events in diabetes: still an open question. , 2008, JAMA.

[3]  T. Morimoto,et al.  Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes , 2012 .

[4]  P. Macfarlane,et al.  The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease , 2008, BMJ : British Medical Journal.

[5]  David Ames,et al.  Feasibility of conducting a primary prevention trial of low‐dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study , 2008, The Medical journal of Australia.

[6]  H. Britt,et al.  Patient-based substudies from BEACH: abstracts and research tools 1999-2006 , 2007 .

[7]  J. Colwell.  Aspirin for primary prevention of cardiovascular events in diabetes. , 2003, Diabetes care.

[8]  J. Charles,et al.  General practice activity in Australia 2002-03 , 2003 .

[9]  C. Mulrow,et al.  Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[10]  Joint British recommendations on prevention of coronary heart disease in clinical practice: summary , 2001, BMJ : British Medical Journal.

[11]  British Cardiac Society,et al.  Joint British recommendations on prevention of coronary heart disease in clinical practice: summary , 2000, BMJ : British Medical Journal.

[12]  J. Colwell.  Aspirin Therapy in Diabetes , 1997, Diabetes Care.